Cargando…
Advances and Future Challenges in Adenoviral Vector Pharmacology and Targeting
Adenovirus is a robust vector for therapeutic applications, but its use is limited by our understanding of its complex in vivo pharmacology. In this review we describe the necessity of identifying its natural, widespread, and multifaceted interactions with the host since this information will be cru...
Autores principales: | Khare, Reeti, Chen, Christopher Y, Weaver, Eric A, Barry, Michael A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267160/ https://www.ncbi.nlm.nih.gov/pubmed/21453281 http://dx.doi.org/10.2174/156652311796150363 |
Ejemplares similares
-
Targeted adenoviral vectors
por: Vigne, E, et al.
Publicado: (2001) -
Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines
por: Zhang, Jianfeng
Publicado: (2012) -
Efficacy of an Adenoviral Vectored Multivalent Centralized Influenza Vaccine
por: Lingel, Amy, et al.
Publicado: (2017) -
Mining the Adenovirus Virome for Oncolytics Against Multiple Solid Tumor Types
por: Chen, Christopher Y., et al.
Publicado: (2011) -
Targeted Adenoviral Vectors I: Transductional Targeting
por: Dmitriev, Igor P., et al.
Publicado: (2016)